Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sellas Life Sciences
Sort By
Newest First
Sign in
1 / 1
1 / 1
Clinical Trials
SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial
SELLAS Life Sciences Group
PR-M04-18-NI-020-4444
Apr 05, 2018
